Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Johnson & Johnson Now a Has-Been in the COVID Vaccine Market?


Johnson & Johnson (NYSE: JNJ) was once viewed as a leader in the COVID-19 vaccine arena. However, various issues have changed that perception in the minds of some. In this Motley Fool Live video recorded on June 9, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not J&J is now a has-been in the COVID-19 vaccine market.

Continue reading


Source Fool.com

Like: 0
JNJ
Share

Comments